Posts Tagged ‘treprostinil’

RSS

January 31st, 2014

A (Not So) New Drug Landscape for Pulmonary Arterial Hypertension

John Ryan offers a primer on three newly approved drugs for pulmonary arterial hypertension.


March 25th, 2013

Once Again FDA Rejects Oral Treprostinil for Pulmonary Arterial Hypertension

For the second time the FDA has issued a complete response letter rejecting the new drug application (NDA) of oral treprostinil for the treatment of pulmonary arterial hypertension (PAH). The manufacturer of the drug, United Therapeutics, said in a press release that it planned to discuss the decision with the FDA. “We remain confident that oral treprostinil will play […]